What is Amplify Surgical?
Amplify Surgical, Inc. operates at the intersection of advanced engineering and clinical efficacy, specializing in the development of innovative endoscopic solutions for spine surgery. The company's flagship dualPortal system represents a paradigm shift in lumbar spine procedures, designed to enhance both the learning curve for surgeons and the precision of execution. Furthermore, their proprietary dualX and dualXSlim implants utilize advanced dual-expanding technology to facilitate minimally-invasive spinal restoration. By providing a comprehensive suite of implants tailored for lateral, transforaminal, and posterior surgical approaches, Amplify Surgical addresses critical gaps in current orthopedic practices, ultimately aiming to improve patient outcomes and streamline surgical workflows for healthcare providers globally.
How much funding has Amplify Surgical raised?
Amplify Surgical has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Amplify Surgical
PPP
Public-Private Partnership
What's next for Amplify Surgical?
With the successful closure of this late-stage financing, Amplify Surgical is poised to scale its operational capabilities and expand its commercial reach. The strategic deployment of this capital will likely focus on broadening the adoption of the dualPortal system and scaling the manufacturing of its dual-expanding implant portfolio. As the company transitions into this next phase of growth, the focus will remain on clinical validation and the expansion of its surgeon-training initiatives. By maintaining a rigorous commitment to technological advancement and surgical excellence, Amplify Surgical is strategically positioned to capture a larger share of the minimally-invasive spine surgery market, setting a new standard for spinal restoration procedures.
See full Amplify Surgical company page
